Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction

Chinese Medical Journal

Volumn 117, Issue 10, 2004, Pages 1443-1448

  Chen, Shao Ling ^a   Fang, Wu Wang ^a   Qian, Jun ^b   Ye, Fei ^a   Liu, Yu Hao ^c   Shan, Shou Jie ^a   Zhang, Jun Jie ^a   Lin, Song ^a   Liao, Lian Ming ^c   Zhao, Robert Chun Hua ^c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Department of Cardiology   (China)

^c PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Acute myocardial infarction; Bone marrow mesenchymal stem cell; Cell transplantation

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART FUNCTION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE WALL MOTION; HEART PERFUSION; HOLTER MONITORING; HUMAN; INJECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL SIGNIFICANCE; SYSTOLE;

ADULT; AGED; BONE MARROW CELLS; FEMALE; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MIDDLE AGED; MYOCARDIAL INFARCTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TRANSPLANTATION, AUTOLOGOUS;

EID: 8844224831     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990;81:1161-1172.
2. Leor J, Patterson M, Quinones MJ, et al. Transplantation of fetal myocardial tissue into infarcted myocardium of rat. A potential method for repair of infarcted myocardium? Circulation 1996;94(9 Suppl):II332-II336.
3. Tomita S, Li RK, Weisel RD, et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 1999;100(19 Suppl):II247-II256.
4. Johnstone B, Hering TM, Caplan AL, et al. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 1998;238:265-272.
5. Jaiswal RK, Jaiswal N, Bruder SP, et al. Adult human mesemchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated proetein kinase. J Biol Chem 2000;275:9645-9652.
6. Woodbury D, Schwarz EJ, Prockop DJ, et al. Adult rat and human bone marrow strolmal cells differentiate into neurons. J Neurosci Res 2000;61:364-370.
7. Jaiswal N, Haynesworth SE, Caplan AI, et al. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 1997;64: 295-312.
8. Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002; 106:1913-1918.
9. Strauer BE, Brehm M, Zeuts T, et al. Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction. Dtsch Med Wochenschr 2001;126:932-938.
10. Samady H, Liu YH, Choi CJ, et al. Electromechanical mapping for detecting myocardial viability and ischemia in patients with severe ischemic cardiomyopathy. Am J Cardiol 2003;91:807-811.
11. Gaudron P, Eilles C, Kugler I, et al. Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors. Circulation 1993;87:755-763.
12. Toma C, Pittenger MF, Cahill KS, et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002;105: 93-98.
13. Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001;7:430-436.
14. Perin EC, Geng YT, Willerson JT, et al. Adults stem cell therapy in perspective. Circulation 2003;107:935-938.
15. Blau HM, Brazelton TR, Weimann JM, et al. The evolving concept of a stem cell: entity or function? Cell 2001;105: 829-841.
16. Murry CE, Wiseman RW, Schwartz SM, et al. Skeletal myoblasts transplantation for repair of myocardial necrosis. J Clin Invest 1996;98:2512-2523.
17. Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 1995;18:1417-1426.
18. Fukuda K. Development of regenerating cardiomyocytes from mesenchymal stem cells for cardiovascular tissue engineering. Artif Organs 2001;25:187-193.
19. Li RK, Mickle RD, Weisel RD, et al. Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury. Ann Thorac Surg 2001;72:1957-1963.
20. Bolognese L, Neskovic AN, Parodi G, et al. Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications. Circulation 2002;106:2351-2357.
21. Smith WH, Kastner RJ, Calnon DA, et al. Quantitative gated single photon emission computed tomography imaging: a counts-based method for display and measurement of regional and global ventricular systolic function. J Nucl Cardiol 1997; 4:451-463.
22. Koch KC, vom Dahl J, Wenderdel M, et al. Myocardial viability assessment by endocardial electroanatomic mapping: comparison with metabolic imaging and functional recovery after coronary revascuarization. J Am Coll Cardiol 2001;38: 91-98.